Class II histone deacetylases: versatile regulators.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Trends in Genetics

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0168-9525(03)00073-8PMID 12711221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

  2003cited by this paper
• Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family*

  2002cited by this paper
• MEF2: a calcium-dependent regulator of cell division, differentiation and death.

  2002cited by this paper
• Isolation and Characterization of Mammalian HDAC10, a Novel Histone Deacetylase*

  2002cited by this paper
• Isolation and Characterization of a Novel Class II Histone Deacetylase, HDAC10*

  2002cited by this paper
• Molecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10*

  2002cited by this paper
• Association of Class II Histone Deacetylases with Heterochromatin Protein 1: Potential Role for Histone Methylation in Control of Muscle Differentiation

  2002cited by this paper
• SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities*

  2002cited by this paper
• The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2.

  2002cited by this paper
• Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes

  2002cited by this paper
• In vivo destabilization of dynamic microtubules by HDAC6‐mediated deacetylation

  2002cited by this paper
• CtBP, an unconventional transcriptional corepressor in development and oncogenesis.

  2002cited by this paper
• Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.

  2002cited by this paper
• Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain.

  2002cited by this paper
• Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

  2002cited by this paper
• MEF2‐mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling

  2002cited by this paper
• HDAC6 is a microtubule-associated deacetylase

  2002cited by this paper
• Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases.

  2002cited by this paper
• Class II Histone Deacetylases Are Directly Recruited by BCL6 Transcriptional Repressor*

  2002cited by this paper
• The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase

  2002cited by this paper
• The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis

  2001cited by this paper
• Nuclear hormone receptors and gene expression.

  2001cited by this paper
• Cloning and characterization of a histone deacetylase, HDAC9

  2001cited by this paper
• Association of COOH-terminal-binding Protein (CtBP) and MEF2-interacting Transcription Repressor (MITR) Contributes to Transcriptional Repression of the MEF2 Transcription Factor*

  2001cited by this paper
• A Dynamic Role for HDAC7 in MEF2-mediated Muscle Differentiation*

  2001cited by this paper
• Identification of Components of the Murine Histone Deacetylase 6 Complex: Link between Acetylation and Ubiquitination Signaling Pathways

  2001cited by this paper
• The emerging role of class II histone deacetylases.

  2001cited by this paper
• The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3

  2001cited by this paper
• Human HDAC7 Histone Deacetylase Activity Is Associated with HDAC3in Vivo *

  2001cited by this paper
• The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program.

  2001cited by this paper
• Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin.

  2001cited by this paper
• Mechanism for Nucleocytoplasmic Shuttling of Histone Deacetylase 7*

  2001cited by this paper
• Differential localization of HDAC4 orchestrates muscle differentiation.

  2001cited by this paper
• Identification of a Signal-Responsive Nuclear Export Sequence in Class II Histone Deacetylases

  2001cited by this paper
• Deletion of Calcineurin and Myocyte Enhancer Factor 2 (MEF2) Binding Domain of Cabin1 Results in Enhanced Cytokine Gene Expression in T Cells

  2001cited by this paper
• Histone Deacetylase 4 Possesses Intrinsic Nuclear Import and Export Signals

  2001cited by this paper
• Control of muscle development by dueling HATs and HDACs.

  2001cited by this paper
• The Modular Nature of Histone Deacetylase HDAC4 Confers Phosphorylation-dependent Intracellular Trafficking*

  2001cited by this paper
• Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

  2000cited by this paper
• Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras.

  2000cited by this paper
• ERK5 Is a Novel Type of Mitogen-Activated Protein Kinase Containing a Transcriptional Activation Domain

  2000cited by this paper
• Integration of calcineurin and MEF2 signals by the coactivator p300 during T‐cell apoptosis

  2000cited by this paper
• Identification of a nuclear domain with deacetylase activity.

  2000cited by this paper
• Both corepressor proteins SMRT and N‐CoR exist in large protein complexes containing HDAC3

  2000cited by this paper
• Calcium Regulates Transcriptional Repression of Myocyte Enhancer Factor 2 by Histone Deacetylase 4*

  2000cited by this paper
• Regulation of Histone Deacetylase 4 by Binding of 14-3-3 Proteins

  2000cited by this paper
• Active maintenance of mHDA2/mHDAC6 histone-deacetylase in the cytoplasm.

  2000cited by this paper
• BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

  2000cited by this paper
• Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.

  2000cited by this paper
• Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization.

  2000cited by this paper
• Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation.

  2000cited by this paper
• Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.

  2000cited by this paper
• Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.

  2000cited by this paper
• The histone deacetylase-3 complex contains nuclear receptor corepressors.

  2000cited by this paper
• Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2.

  2000cited by this paper
• A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness.

  2000cited by this paper
• Review: chromatin structural features and targets that regulate transcription.

  2000cited by this paper
• Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases.

  2000cited by this paper
• BCoR, a novel corepressor involved in BCL-6 repression.

  2000cited by this paper
• Acetylation and chromosomal functions.

  2000cited by this paper
• Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5.

  2000cited by this paper
• mHDA1/HDAC5 Histone Deacetylase Interacts with and Represses MEF2A Transcriptional Activity*

  2000cited by this paper
• Ca2+-dependent Gene Expression Mediated by MEF2 Transcription Factors*

  2000cited by this paper
• Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway.

  2000cited by this paper
• 14-3-3 proteins: regulation of subcellular localization by molecular interference.

  2000cited by this paper
• MEF‐2 function is modified by a novel co‐repressor, MITR

  1999cited by this paper
• Calcineurin Enhances MEF2 DNA Binding Activity in Calcium-dependent Survival of Cerebellar Granule Neurons*

  1999cited by this paper
• Neuronal activity-dependent cell survival mediated by transcription factor MEF2.

  1999cited by this paper
• Identification of a New Family of Higher Eukaryotic Histone Deacetylases

  1999cited by this paper
• HDAC4 deacetylase associates with and represses the MEF2 transcription factor

  1999cited by this paper
• Three proteins define a class of human histone deacetylases related to yeast Hda1p.

  1999cited by this paper
• A New Family of Human Histone Deacetylases Related toSaccharomyces cerevisiae HDA1p*

  1999cited by this paper
• HDAC4, a Human Histone Deacetylase Related to Yeast HDA1, Is a Transcriptional Corepressor

  1999cited by this paper
• Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2.

  1999cited by this paper
• Components of the SMRT Corepressor Complex Exhibit Distinctive Interactions with the POZ Domain Oncoproteins PLZF, PLZF-RARα, and BCL-6*

  1998cited by this paper
• The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT

  1998cited by this paper
• Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.

  1997cited by this paper
• Cyclosporin A‐sensitive induction of the Epstein‐Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member

  1997cited by this paper
• Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis

  1995cited by this paper
• A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection.

  1995cited by this paper
• Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas

  1994cited by this paper
• LAZ3, a novel zinc–finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas

  1993cited by this paper
• Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma.

  1993cited by this paper
• Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor.

  1989cited by this paper
• A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene.

  1988cited by this paper
• The steroid and thyroid hormone receptor superfamily.

  1988cited by this paper
• Microtubules containing acetylated alpha-tubulin in mammalian cells in culture

  1987cited by this paper
• Persisting oncogenic herpesvirus induced by the tumour promoter TPA

  1978cited by this paper
• Activation of latent Epstein–Barr virus by antibody to human IgM

  1978cited by this paper

• Structural Modifications and Prospects of Histone Deacetylase (HDAC) Inhibitors in Cancer.

  2025cites this paper
• Interactome Profiling of a Lysine Deacetylase Trapping Probe Library Uncovers Crosstalk Between HDAC6 and NF‐κB Signaling

  2025cites this paper
• HDAC4/5 Inhibitor, LMK‐235 Improves Animal Voluntary Movement in MPTP‐Induced Parkinson's Disease Model

  2025cites this paper
• Modelling-filtered drug repurposing and first-in-protein SPR validation of histone deacetylase 4 inhibitors for Ataxia-telangiectasia.

  2025cites this paper
• Histone deacetylases in myocardial infarction: Orchestrating programmed cell death pathways and emerging therapeutic opportunities.

  2025cites this paper
• Mapping the Interactions Among Class IIa Histone Deacetylases and Myocyte Enhancer Factor 2s

  2025cites this paper
• Harnessing Histone Deacetylase Inhibitors for Enhanced Cancer Immunotherapy.

  2025cites this paper
• Multifaceted roles of HDAC7 in disease and the evolving chemical toolkit for its modulation.

  2025cites this paper
• MYC plus class IIa HDAC inhibition drives mitochondrial dysfunction in non-small cell lung cancer.

  2025cites this paper
• A comprehensive review on azole-based hydroxamic acid analogs as histone deacetylases (HDACs) inhibitors.

  2025cites this paper
• Epigenetic programming of macrophages across inflammatory and malignant diseases.

  2025cites this paper
• Scaffolding Activities of Pseudodeacetylase HDAC7.

  2025cites this paper
• The inhibitory and anti-inflammatory effects of TMP269 on peste des petits ruminants virus replication

  2025cites this paper
• Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology

  2024cites this paper
• Unraveling the mechanism of microRNA-134 in colon cancer progression: targeting KRAS and PIK3CA for cell cycle control and histone deacetylase regulation.

  2024cites this paper
• Effect of HDAC9 on the differentiation of chicken embryonic stem cells into male germ cells

  2024cites this paper
• Characterization of molecular interactions between HDAC7 and MEF2A.

  2024cites this paper
• Upregulation of ISG15 induced by MAPT/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease

  2024cites this paper
• Regulation of cardiovascular diseases by histone deacetylases and NADPH oxidases

  2024cites this paper
• Unveiling the role of histone deacetylases in neurological diseases: focus on epilepsy

  2024cites this paper
• The efficacy of botanical drugs in orchestrating epigenetic modifications for ameliorating metabolic disorders

  2024cites this paper
• HDAC7 promotes cardiomyocyte proliferation by suppressing myocyte enhancer factor 2

  2024cites this paper
• Epigenetic modifications in the development of bronchopulmonary dysplasia: a review

  2024cites this paper
• Folding of class IIa HDAC derived peptides into α-helices upon binding to myocyte enhancer factor-2 in complex with DNA.

  2024cites this paper
• Loss of Hdac4 in osteoprogenitors impairs postnatal trabecular and cortical bone formation, resulting in a dwarfism and osteopenia phenotype in mice

  2024cites this paper
• Structural insights into the HDAC4–MEF2A–DNA complex and its implication in long-range transcriptional regulation

  2024cites this paper
• Histone deacetylase 9-mediated phenotypic transformation of vascular smooth muscle cells is a potential target for treating aortic aneurysm/dissection.

  2024cites this paper
• PsA inhibits the development of bovine embryos through epigenetic and oxidative stress.

  2023cites this paper
• Epigenetic effects of herbal medicine

  2023cites this paper
• Pleiotropic influence of DNA methylation QTLs on physiological and ageing traits

  2023cites this paper
• HDAC1: An Essential and Conserved Member of the Diverse Zn2+-Dependent HDAC Family Driven by Divergent Selection Pressure

  2023cites this paper
• Stroke by inducing HDAC9-dependent deacetylation of HIF-1 and Sp1, promotes TfR1 transcription and GPX4 reduction, thus determining ferroptotic neuronal death

  2023cites this paper
• Epigenetic regulation by quercetin: a comprehensive review focused on its biological mechanisms

  2023influential citation
• Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy

  2023cites this paper
• The emerging roles of HDACs and their therapeutic implications in cancer.

  2022cites this paper
• Yeast beta-glucan mediates histone deacetylase 5-induced angiogenesis in vascular endothelial cells.

  2022cites this paper
• Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation

  2022cites this paper
• Epigenetic Regulation of Chondrocytes and Subchondral Bone in Osteoarthritis

  2022cites this paper
• Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats

  2022cites this paper
• ZFP541 maintains the repression of pre-pachytene transcriptional programs and promotes male meiosis progression.

  2022cites this paper
• Histone Deacetylase Inhibitors, Intrinsic and Extrinsic Apoptotic Pathways, and Epigenetic Alterations of Histone Deacetylases (HDACs) in Hepatocellular Carcinoma

  2021cites this paper
• Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy.

  2021cites this paper
• HDAC4 Inhibitors with Cyclic Linker and Non‐hydroxamate Zinc Binding Group: Design, Synthesis, HDAC Screening and in   vitro Cytotoxicity evaluation.

  2021cites this paper
• Panobinostat reverses HepaCAM gene expression and suppresses proliferation by increasing histone acetylation in prostate cancer.

  2021cites this paper
• HDAC6 Substrate Discovery Using Proteomics-Based Substrate Trapping: HDAC6 Deacetylates PRMT5 to Influence Methyltransferase Activity.

  2021cites this paper
• Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer

  2021cites this paper
• How Influenza Virus Uses Host Cell Pathways during Uncoating

  2021cites this paper
• Chemo-proteomics exploration of HDAC degradability by small molecule degraders.

  2021cites this paper
• Signals for antigen-independent differentiation of memory CD8+ T cells

  2021cites this paper
• The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau

  2021cites this paper
• Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders.

  2021cites this paper
• The role of miR‐29 family in disease

  2021cites this paper
• Angiotensin II-Induced Histone Deacetylase 5 Phosphorylation, Nuclear Export and Egr-1 Expression is mediated by Akt Pathway in A10 Vascular Smooth Muscle Cells.

  2021cites this paper
• Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer’s Disease

  2021cites this paper
• Epigenetic Enzymes: A Role in Aging and Prospects for Pharmacological Targeting.

  2021cites this paper
• Histone deacetylase 10, a potential epigenetic target for therapy

  2021cites this paper
• Mapping of cis-acting expression quantitative trait loci in human scalp hair follicles

  2020cites this paper
• Proteomic Investigation of Interferon Alpha Stimulation and Viral Regulation to Identify Candidate Antiviral Restriction Factors

  2020cites this paper
• Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer

  2020cites this paper
• AtHDA15 binds directly to COP1 positively regulating photomorphogenesis.

  2020cites this paper
• Present and future perspectives for targeting histone modifications in therapy

  2020cites this paper
• Ovarian preantral follicles are responsive to FSH as early as the primary stage of development.

  2020cites this paper
• Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice

  2020cites this paper
• HC-toxin.

  2020cites this paper
• Missense substitutions at a conserved 14-3-3 binding site in HDAC4 cause a novel intellectual disability syndrome

  2020cites this paper
• Structure of Arabidopsis HISTONE DEACETYLASE151[OPEN]

  2020cites this paper
• Transcriptional, epigenetic and microRNA regulation of growth plate.

  2020cites this paper
• Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer.

  2020cites this paper
• Pseudophosphatase MK‐STYX: the atypical member of the MAP kinase phosphatases

  2020cites this paper
• Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy

  2020cites this paper
• HDAC4 Regulates the Proliferation, Differentiation and Apoptosis of Chicken Skeletal Muscle Satellite Cells

  2020cites this paper
• Structure of Arabidopsis HISTONE DEACETYLASE15.

  2020cites this paper
• Histone Acetylation as a Regenerative Target in the Dentine-Pulp Complex

  2020cites this paper
• A short guide to histone deacetylases including recent progress on class II enzymes

  2020cites this paper
• FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells.

  2020cites this paper
• Summa of Erasers of Histone Acetylation with Special Emphasis on Classical Histone Deacetylases (HDACs)

  2020cites this paper
• Epigenetic Therapy as a Putative Molecular Target to Modulate B Cell Biology and Behavior in the Context of Immunological Disorders

  2020cites this paper
• Molecular docking-based virtual drug screening revealing an oxofluorenyl benzamide and a bromonaphthalene sulfonamido hydroxybenzoic acid as HDAC6 inhibitors with cytotoxicity against leukemia cells.

  2020cites this paper
• Histone Deacetylase Inhibitors: A Novel Strategy In Trauma And Sepsis.

  2019cites this paper
• Protein kinase A-mediated novel Serine 584 phosphorylation of HDAC4.

  2019cites this paper
• Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers

  2019cites this paper
• Recent Perspectives of Anticancer Histone Deacetylase Inhibitors

  2019cites this paper
• The compound 33i,a new sirt2 inhibitor, as a potential treatment for Alzheimer's disease

  2019cites this paper
• Effects of aerobic and inspiratory training on skeletal muscle microRNA‐1 and downstream‐associated pathways in patients with heart failure

  2019cites this paper
• Recent advances in class IIa histone deacetylases research.

  2019cites this paper
• Pseudophosphatase MK-STYX Alters Histone Deacetylase 6 Cytoplasmic Localization, Decreases Its Phosphorylation, and Increases Detyrosination of Tubulin

  2019cites this paper
• Targeted Inhibition of Histone Deacetyltransferases for Pancreatic Cancer Therapy

  2019cites this paper
• Atherosclerosis and flow: roles of epigenetic modulation in vascular endothelium

  2019cites this paper
• HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms

  2019cites this paper
• Harnessing the HDAC–histone deacetylase enzymes, inhibitors and how these can be utilised in tissue engineering

  2019cites this paper
• Dopamine receptor antagonists as potential therapeutic agents for ADPKD

  2019cites this paper
• Epigenomic mechanisms of alcohol-induced impaired differentiation of skeletal muscle stem cells; role of Class IIA histone deacetylases.

  2019cites this paper
• Histone Deacetylase-linked Repression and Metabolically-linked Derepression of Adenovirus Persistent Infection of Lymphocytes

  2019cites this paper
• Pharmacoepigenetics of Histone Deacetylase Inhibitors in Cancer

  2019cites this paper
• From phenotype to function via mass spec-based proteomics

  2019cites this paper
• In silico Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity

  2019cites this paper
• Docking analysis provide structural insights to design novel ligands that target PKM2 and HDC8 with potential use for cancer therapy

  2019cites this paper
• Histone deacetylase 4 (HDAC4): a new player in anorexia nervosa?

  2019cites this paper
• Identification of Compounds That Inhibit Estrogen-Related Receptor Alpha Signaling Using High-Throughput Screening Assays

  2019cites this paper
• Epigenetics in infectious disease

  2019cites this paper